» Articles » PMID: 36353512

Single-cell and Single-nuclei RNA Sequencing As Powerful Tools to Decipher Cellular Heterogeneity and Dysregulation in Neurodegenerative Diseases

Overview
Specialty Cell Biology
Date 2022 Nov 10
PMID 36353512
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases affect millions of people worldwide and there are currently no cures. Two types of common neurodegenerative diseases are Alzheimer's (AD) and Parkinson's disease (PD). Single-cell and single-nuclei RNA sequencing (scRNA-seq and snRNA-seq) have become powerful tools to elucidate the inherent complexity and dynamics of the central nervous system at cellular resolution. This technology has allowed the identification of cell types and states, providing new insights into cellular susceptibilities and molecular mechanisms underlying neurodegenerative conditions. Exciting research using high throughput scRNA-seq and snRNA-seq technologies to study AD and PD is emerging. Herein we review the recent progress in understanding these neurodegenerative diseases using these state-of-the-art technologies. We discuss the fundamental principles and implications of single-cell sequencing of the human brain. Moreover, we review some examples of the computational and analytical tools required to interpret the extensive amount of data generated from these assays. We conclude by highlighting challenges and limitations in the application of these technologies in the study of AD and PD.

Citing Articles

Advancements in single-cell RNA sequencing and spatial transcriptomics: transforming biomedical research.

Molla Desta G, Birhanu A Acta Biochim Pol. 2025; 72:13922.

PMID: 39980637 PMC: 11835515. DOI: 10.3389/abp.2025.13922.


Genetic Analysis of Retinal Cell Types in Neuropsychiatric Disorders.

Boudriot E, Stephan M, Rabe F, Smigielski L, Schmitt A, Falkai P JAMA Psychiatry. 2025; 82(3):285-295.

PMID: 39775833 PMC: 11883512. DOI: 10.1001/jamapsychiatry.2024.4230.


Unraveling Alzheimer's disease: insights from single-cell sequencing and spatial transcriptomic.

He Y, Lu W, Zhou X, Mu J, Shen W Front Neurol. 2025; 15:1515981.

PMID: 39741706 PMC: 11685091. DOI: 10.3389/fneur.2024.1515981.


A most important gift: the critical role of postmortem brain tissue in autism science.

Natowicz M, Bauman M, Edelson S Front Neurol. 2024; 15:1486227.

PMID: 39726759 PMC: 11670190. DOI: 10.3389/fneur.2024.1486227.


The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies.

Hashmi M, Fatima H, Ahmad S, Rehman A, Safdar F Ibrain. 2024; 10(4):395-426.

PMID: 39691424 PMC: 11649393. DOI: 10.1002/ibra.12183.


References
1.
Street K, Risso D, Fletcher R, Das D, Ngai J, Yosef N . Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics. 2018; 19(1):477. PMC: 6007078. DOI: 10.1186/s12864-018-4772-0. View

2.
Campbell K, Yau C . A descriptive marker gene approach to single-cell pseudotime inference. Bioinformatics. 2018; 35(1):28-35. PMC: 6298060. DOI: 10.1093/bioinformatics/bty498. View

3.
Kotliar D, Veres A, Nagy M, Tabrizi S, Hodis E, Melton D . Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq. Elife. 2019; 8. PMC: 6639075. DOI: 10.7554/eLife.43803. View

4.
Cuevas-Diaz Duran R, Wei H, Wu J . Single-cell RNA-sequencing of the brain. Clin Transl Med. 2017; 6(1):20. PMC: 5465230. DOI: 10.1186/s40169-017-0150-9. View

5.
Kharchenko P . The triumphs and limitations of computational methods for scRNA-seq. Nat Methods. 2021; 18(7):723-732. DOI: 10.1038/s41592-021-01171-x. View